Curaleaf (OTCMKTS:CURLF) Shares to Reverse Split on Friday, June 5th

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock is going to reverse split on the morning of Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, June 4th.

Curaleaf Price Performance

OTCMKTS CURLF opened at $3.16 on Thursday. Curaleaf has a one year low of $0.72 and a one year high of $5.05. The stock has a 50-day moving average of $2.92 and a 200 day moving average of $2.67. The company has a market capitalization of $2.21 billion, a price-to-earnings ratio of -24.31 and a beta of 1.58. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of ($0.08) by $0.17. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The company had revenue of $324.23 million during the quarter, compared to the consensus estimate of $316.62 million. On average, sell-side analysts forecast that Curaleaf will post -0.1 EPS for the current year.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three investment analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Strong Buy”.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.